Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients

Not Applicable

Terminated

• Conditions: Depression; Asthma; Urticaria
• Interventions: Behavioral: Brief Behavioral Activation Intervention

• Registration Number: NCT02382562
• Lead Sponsor: University of Mississippi Medical Center

Brief Summary

Depression and other unhealthy behaviors, such as not taking medication as prescribed and not attending doctor visits have been suggested to increase the worsening of allergic diseases (e.g. asthma, urticaria). We intend to determine whether a one-session behavioral intervention is effective in helping with depression and controlling disease symptoms. We will measure this using pre- and post-intervention surveys.

Detailed Description

The purpose of this research study is to investigate whether a one-session behavioral activation intervention for depression can successfully reduce depression and improve asthma or urticaria disease-relevant outcomes (medication adherence, doctor's visits, substance abuse) in clinical patients with asthma or urticaria who report heightened levels of depression and are seen in the UMMC Allergy Clinic.

Study Timeline

• Study First Submitted: 2015-03-02
• Study First Submitted QC: 2015-03-02
• Study First Posted: 2015-03-06
• Study Start: 2015-05
• Primary Completion: 2016-03
• Study Completion: 2016-10-17
• Status Verified: 2018-04
• Last Update Submitted: 2018-04-17
• Last Update Posted: 2018-04-19

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

• Potential participants should be between the ages 18 and 64, seen in the UMMC Allergy Clinic with either asthma or urticaria and who report symptoms of depression in the previous 2 weeks.

Exclusion Criteria

• Potential participants younger than 18 and older than 64 or who do not speak English or cannot comprehend the consent form or women who are pregnant are excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Brief Behavioral Activation Intervention	Brief Behavioral Activation Intervention	All eligible participants will undergo the Brief Behavioral Activation Intervention.

Primary Outcome Measures

Name	Time	Method
Urticaria Control Test	4 weeks	Changes in urticaria control over a 4 week period.
Asthma Control Test	4 weeks	Changes in asthma control over a 4 week period.

Secondary Outcome Measures

Name	Time	Method
Asthma Quality of Life Questionnaire	4 weeks	Changes in asthma quality of life over a 4 week period.
Psychological Measures (Composite)	4 weeks	Effects of brief behavioral activation intervention based upon psychological differences including depression and anxiety measured over a 4 week period.
Urticaria Activity Score Questionnaire	4 weeks	Changes in the activity of urticaria over a 4 week period.

Trial Locations

Locations (1)

University of Mississippi Medical Center - Allergy, Immunology and Asthma Care Clinic; 🇺🇸 Jackson, Mississippi, United States